Canid, a healthcare technology company focused on streamlining pediatric vaccine management, has closed a $10 million Series A funding round led by Telescope Partners, with participation from FJ Labs, Brooklyn Bridge Ventures, SeedtoB and other investors. The investment brings the company's total funding to $12.9 million and will support its expansion across independent pediatric practices in the United States.
The funding addresses a significant operational challenge in pediatric care, where vaccinations represent the second-largest expense after staff salaries for most practices. Despite this substantial investment, 69% of pediatricians either break even or lose money on their vaccine programs due to complications with insurance reimbursement, inventory management, and administrative overhead. These financial pressures contribute to the ongoing consolidation wave affecting independent practices nationwide.
Canid's platform transforms the traditionally manual vaccine management process into an automated workflow through barcode scanning technology. When pediatricians scan a vaccine barcode, the system automatically handles all related administrative work, financial risk, and public health compliance requirements. The platform integrates directly with electronic health records and uses a combination of artificial intelligence, software, and economies of scale to execute tasks that previously consumed hours of staff time.
The comprehensive solution encompasses automated logistics for ordering, reporting, and billing; guaranteed payments with no inventory risk; and data-driven patient outreach capabilities that identify under-vaccinated children to improve completion rates. This approach addresses the growing administrative burden on physicians, who now spend an average of 15 hours per week on administrative tasks, up from nine hours in 2012, according to Medscape's annual physician compensation report.
"Pediatricians spend years training to provide exceptional care for children, not to become experts in revenue cycle management or inventory systems," said Canid CEO and founder Pedro Sánchez de Lozada. "By handling all the business-side tasks and operations, our platform frees them up to focus on treating patients. We believe Canid will be the technology backbone that allows independent pediatric practices to thrive."
Early adopters of the platform report significant operational improvements. "When you run an independent practice, all the little costs add up. Vaccine management is full of those little costs," said Dr. Julie Capiola, partner at Premier Pediatrics, which joined Canid's platform in January 2023. "Canid is a true partner for us, embedding themselves in our practice so they can fully handle everything related to our vaccine program on our behalf. This saves the practice money but, most importantly, gives me back time to spend doing what matters most: caring for patients."
Since its founding in 2021, Canid has grown to partner with more than 150 pediatricians across 12 states, serving patient panels that include over 300,000 children. The company has facilitated vaccinations for 121,000 patients to date.
"Canid is addressing a major pain point for a critically important population: the doctors who take care of our children," said Nicole Naidoo, Partner at Telescope Partners. "Canid's platform transforms their vaccination programs from financial burden to efficient operation. We're excited to support the company as it brings pediatric vaccine management into the modern era."
Click here for the original news story.